|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.550
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.465
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.373
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.350
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.337
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.316
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.286
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.280
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.263
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.262
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.261
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.243
|
Mouse |
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.242
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.231
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.225
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.223
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.223
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.220
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.208
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.208
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.206
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.206
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.201
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.182
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.175
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.173
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.172
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.168
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.166
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.165
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.165
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.163
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.161
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.150
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.146
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.144
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.140
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.138
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.137
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.136
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.130
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.128
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.125
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.124
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.123
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.122
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.118
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.118
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.114
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.114
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.113
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.113
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.111
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.111
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.111
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.110
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.110
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.109
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.108
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.108
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.108
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.108
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.107
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.106
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.104
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.104
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.104
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.104
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.104
|
|
|
|
learning
|
GO:0007612 |
98 |
0.102
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.101
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.099
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.099
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.099
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.097
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.097
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.097
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.096
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.095
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.095
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.094
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.093
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.089
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.089
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.088
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.087
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.087
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.086
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.085
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.085
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.085
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.084
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.084
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.083
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.082
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.082
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.081
|
Mouse |
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.080
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.080
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.079
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.079
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.079
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.078
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.078
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.078
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.076
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.076
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.075
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.075
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.074
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.073
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.072
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.072
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.071
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.070
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.070
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.070
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.070
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.070
|
Mouse |
|
|
limb development
|
GO:0060173 |
166 |
0.070
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.069
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.069
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.069
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.069
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.068
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.068
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.067
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.067
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.067
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.067
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.066
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.066
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.065
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.065
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.065
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.064
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.063
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.063
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.062
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.062
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.061
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.061
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.061
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.061
|
Mouse |
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.061
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.061
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.061
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.060
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.059
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.059
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.059
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.059
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.059
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.058
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.058
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.058
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.058
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.058
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.058
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.058
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.057
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.057
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.057
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.057
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.057
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.056
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.056
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.056
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.056
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.056
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.056
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.056
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.055
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.055
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.055
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.055
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.055
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.055
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.055
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.054
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.054
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.053
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.053
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.053
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.053
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.053
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.053
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.052
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.052
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.052
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.052
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.052
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.051
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.051
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.051
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.050
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.050
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.050
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.050
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.050
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.050
|
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.049
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.049
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.049
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.049
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.049
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.049
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.049
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.049
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.049
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.049
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.049
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.048
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.048
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.048
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.048
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.047
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.047
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.047
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.047
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.046
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.046
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.046
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.046
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.046
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.046
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.046
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.046
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.046
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.046
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.046
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.046
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.045
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.045
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.045
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.045
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.045
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.045
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.044
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.044
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.044
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.044
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.044
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.044
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.044
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.044
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.044
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.044
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.044
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.043
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.043
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.043
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.043
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.043
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.043
|
|
|
|
regulation of establishment of planar polarity involved in neural tube closure
|
GO:0090178 |
15 |
0.043
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.043
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.042
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.042
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.042
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.042
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.042
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.042
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.042
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.041
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.041
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.041
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.041
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.041
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.040
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.040
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.040
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.040
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.040
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.040
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.040
|
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.040
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.040
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.040
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.040
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.040
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.039
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.039
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.039
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.039
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.039
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.039
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.039
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.038
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.038
|
|
|
|
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure
|
GO:0001988 |
1 |
0.038
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.038
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.038
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.038
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.038
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.038
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.038
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.038
|
|
|
|
spinal cord motor neuron cell fate specification
|
GO:0021520 |
13 |
0.038
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.038
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.038
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.037
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.037
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.037
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.037
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.037
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.037
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.037
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.037
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.037
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.037
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.037
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.037
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.037
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.036
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.036
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.036
|
|
|
|
respiratory system process
|
GO:0003016 |
25 |
0.036
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.036
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.036
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.036
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.036
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.036
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.036
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.036
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.035
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.035
|
|
|
|
planar cell polarity pathway involved in neural tube closure
|
GO:0090179 |
14 |
0.035
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.035
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.035
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.035
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.035
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.035
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.035
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.035
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.035
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.035
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.035
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.035
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.035
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.035
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.034
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.034
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.034
|
|
|
|
sympathetic nervous system development
|
GO:0048485 |
22 |
0.034
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.034
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.034
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.034
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.034
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.034
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.033
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.033
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.033
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.033
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.033
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.033
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.033
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.033
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.033
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.033
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.033
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.033
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.032
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.032
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.032
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.032
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.032
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.032
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.032
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.032
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.031
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.031
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.031
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.031
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.031
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.031
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.031
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.031
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.031
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.031
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.031
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.031
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.031
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.031
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.030
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.030
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.030
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.030
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.030
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.030
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.030
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.030
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.030
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.030
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.030
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.030
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.030
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.030
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.029
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.029
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.029
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.029
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
22 |
0.029
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.029
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.029
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.029
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.029
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.029
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.029
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.028
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.028
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.028
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.028
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.028
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.028
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.028
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.028
|
|
|
|
forebrain neuron development
|
GO:0021884 |
30 |
0.028
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.028
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.028
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.028
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.028
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.028
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.027
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.027
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.027
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.027
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.027
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.027
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.027
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.027
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.027
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.027
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.027
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.027
|
Mouse |
|
|
endocytosis
|
GO:0006897 |
168 |
0.027
|
Mouse |
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.027
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.027
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.027
|
|
|
|
retinal bipolar neuron differentiation
|
GO:0060040 |
5 |
0.027
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.027
|
|
|
|
dorsal ventral neural tube patterning
|
GO:0021904 |
28 |
0.027
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.027
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.027
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.027
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.027
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.027
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.026
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.026
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.026
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.026
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.026
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.026
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.026
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.026
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.026
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.026
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.026
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.026
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.026
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.026
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.026
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.025
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.025
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.025
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.025
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.025
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.025
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.025
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.025
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.025
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.025
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.025
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.025
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.025
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.025
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.025
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.025
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.025
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.025
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.025
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.025
|
|
|
|
negative regulation of muscle cell differentiation
|
GO:0051148 |
33 |
0.024
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.024
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.024
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.024
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.024
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.024
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.024
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.024
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.024
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.024
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.024
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.024
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.024
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.024
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.024
|
|